Table 1.
Endpoint | CHR/POS (hg38) | REF/ALT | Freqa | Odds Ratio (95% CI)b | p | Heterogeneity p | Gene | Function | Cases | Controls | Number of biobanks |
---|---|---|---|---|---|---|---|---|---|---|---|
Novel | |||||||||||
AAA | 10:73913343 | T/C | 0.737 | 0.88 (0.85–0.91) | 5.93 × 10−12 | 0.76 | PLAU | missense | 9,453 | 1,446,422 | 11 |
COPD | 1:149934520 | T/C | 0.350 | 1.04 (1.03–1.05) | 7.91 × 10−10 | 0.54 | MTMR11 | missense | 79,844 | 1,289,683 | 15 |
Stroke | 6:49492265 | A/G | 0.446 | 0.96 (0.94–0.97) | 1.8 × 10−11 | 0.99 | CENPQ | missense | 60,176 | 1,310,725 | 16 |
Asthma | 10:94279840 | G/C | 0.448 | 1.03 (1.02–1.03) | 2.52 × 10−9 | 0.98 | PLCE1 | missense | 153,763 | 1,647,022 | 18 |
Asthma | 14:100883117 | G/T | 0.025 | 1.09 (1.05–1.12) | 2.61 × 10−8 | 0.73 | RTL1 | missense | 133,369 | 1,370,606 | 16 |
Asthma | 19:56222056 | C/A | 0.253 | 1.03 (1.02–1.04) | 2.35 × 10−8 | 0.60 | ZSCAN5A | missense | 149,293 | 1,626,581 | 17 |
Known | |||||||||||
COPD | 14:94378610 | C/T | 0.020 | 1.22 (1.16–1.29) | 5.2 × 10−15 | 9.27 × 10−3 | SERPINA1 | missense | 54,105 | 883,399 | 11 |
COPD | 19:44908684 | T/C | 0.140 | 0.95 (0.94–0.97) | 1.04 × 10−8 | 0.36 | APOE | missense | 81,568 | 1,310,798 | 16 |
Gout | 2:27508073 | T/C | 0.588 | 0.87 (0.86–0.88) | 9.27 × 10−64 | 0.11 | GCKR | missense | 37,105 | 1,448,128 | 15 |
Gout | 11:64593747 | G/A | 0.016 | 0.36 (0.31–0.42) | 1.19 × 10−41 | 0.10 | SLC22A12 | stop gain | 6,634 | 248,305 | 2 |
Gout | 12:57449928 | G/A | 0.194 | 0.91 (0.89–0.93) | 1.51 × 10−17 | 0.45 | INHBC | missense | 37,105 | 1,448,128 | 15 |
IPF | 5:1279370 | T/C | 0.001 | 862 (205–3618) | 2.66 × 10−20 | 0.09 | TERT | missense | 1,278 | 330,954 | 2 |
IPF | 5:169588475 | G/A | 0.014 | 2.19 (1.81–2.66) | 1.61 × 10−15 | 0.02 | SPDL1 | missense | 4,812 | 882,416 | 7 |
POAG | 1:11193760 | C/T | 0.026 | 0.67 (0.6–0.74) | 4.39 × 10−14 | 0.90 | ANGPTL7 | missense | 12,810 | 421,360 | 5 |
POAG | 1:171636338 | G/A | 0.002 | 6.33 (4.71–8.51) | 1.67 × 10−34 | 4.33 × 10−6 | MYOC | stop gain | 15,916 | 1,092,446 | 11 |
POAG | 14:60509819 | C/A | 0.547 | 0.89 (0.87–0.91) | 7.08 × 10−30 | 0.31 | SIX6 | missense | 26,848 | 1,460,599 | 15 |
Stroke | 12:111803962 | G/A | 0.238 | 0.9 (0.88–0.92) | 5.16 × 10−18 | 0.37 | ALDH2 | missense | 23,804 | 269,656 | 4 |
VTE | 1:169549811 | C/T | 0.020 | 3.04 (2.85–3.24) | 1.5 × 10−245 | 5.52 × 10−13 | F5 | missense | 26,749 | 1,011,509 | 9 |
VTE | 12:6034818 | T/C | 0.889 | 1.1 (1.07–1.13) | 1.59 × 10−10 | 0.21 | VWF | missense | 27,987 | 1,035,290 | 9 |
VTE | 12:103742510 | C/T | 0.011 | 1.65 (1.45–1.88) | 6.19 × 10−14 | 0.25 | STAB2 | missense | 10,353 | 341,418 | 2 |
Asthma | 1:12115601 | G/A | 0.012 | 0.85 (0.8–0.89) | 1.7 × 10−11 | 0.46 | TNFRSF8 | missense | 118,767 | 1,202,660 | 12 |
Asthma | 1:31699894 | G/T | 0.573 | 1.03 (1.02–1.04) | 1.61 × 10−10 | 0.49 | COL16A1 | missense | 148,045 | 1,579,632 | 17 |
Asthma | 4:38797027 | C/A | 0.387 | 0.95 (0.94–0.96) | 4.21 × 10−21 | 0.54 | TLR1 | missense | 138,764 | 1,458,022 | 15 |
Asthma | 4:102267552 | C/T | 0.044 | 1.08 (1.06–1.1) | 2.53 × 10−12 | 0.81 | SLC39A8 | missense | 129,434 | 1,256,670 | 14 |
Asthma | 5:14610200 | C/G | 0.084 | 1.07 (1.05–1.09) | 7.68 × 10−15 | 0.16 | OTULINL | missense | 125,483 | 1,241,068 | 13 |
Asthma | 9:128721272 | T/A | 0.068 | 0.95 (0.93–0.96) | 5.61 × 10−10 | 0.21 | ZDHHC12 | missense | 152,469 | 1,638,824 | 18 |
Frequencies are reported with respect to the alternate allele (ALT) in the combined meta-analysis datasets.
Odds ratios are reported with respect to the alternate allele (ALT) in the meta-analyses.